Citation: | JI Bo, WANG Qifei, MU Yushu, ZHANG Zhihui. Application value of joint detection of tumor markers in assisted diagnosis of lung cancer[J]. Journal of Clinical Medicine in Practice, 2013, (17): 32-35. DOI: 10.7619/jcmp.201317010 |
Hur J, Lee H J, Nam J E. Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer [J]. BMC Cancer, 2012.392.
|
YuD, DuK, LiuT. Prognostic Valueof Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC Patients [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013(6):11145.
|
Pan J B, Hou Y H, Zhang G J. Correlation Between EGFR Mutations and Serum Tumor Markers in Lung Adenocarcinoma Patients [J]. Asian Pacific Journal of Cancer Prevention, 2013(2):695.
|
Nordgrd O, Singh G, Solberg S. Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer [J]. PLoS One, 2013(5):e62153.
|
Grunnet M, Sorensen J B. Carcinoembryonic antigen (CEA)as tumor marker in lung cancer [J]. Lung Cancer, 2012(2):138.
|
Lin X F, Wang X D. High Serum CEA and CYFRA21-1 Levels after a two-cycle adjuvant chemotherapy for NSCLC:possible poor prognostic factors [J]. Cancer Biology & Medicine, 2012(4):270.doi: 10.7497/j.issn.2095-3941.2012.04.009.
|
Wang Y, Tang D, Sui A. Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib [J]. Clinical and Translational Oncology, 2013(5):384.
|
Liu L, Liu B, Zhu L L. Clinical significance of CYFRA21-1, Scc-Ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer [J]. Bioanalysis, 2012, (19):2367.
|
Choi W I, Qama D, Lee M Y. Pleural cancer antigen125 levels in benign and malignant pleural effusions [J]. International Journal of Tuberculosis and Lung Disease, 2013(5):693.
|
Einama T, Kamachi H, Nishihara H. Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma [J]. Pancreas, 2011(8):1276.
|
Okarnura K, Takayama K, Izumi M. Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer [J]. Lung Cancer, 2013(1):45.
|
Cedrés S, Nu I, Longo M. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC) [J]. Clinical Lung Cancer, 2011(3):172.
|